Skip to main content
IMMUPHARMA PLC logo

IMMUPHARMA PLC — Investor Relations & Filings

Ticker · IMM ISIN · GB0033711010 LEI · 213800VZKGHXC7VUS895 IL Professional, scientific and technical activities
Open in API
Filings indexed 443 across all filing types
Latest filing 2022-01-10 Major Shareholding Noti…
Country GB United Kingdom
Listing IL IMM

About IMMUPHARMA PLC

https://www.immupharma.co.uk/

ImmuPharma PLC is a specialty biopharmaceutical company that discovers and develops peptide-based therapeutics. The company's primary focus is on creating novel treatments for serious medical conditions with significant unmet needs. Its core activities involve advancing a pipeline of drug candidates through research and various stages of clinical development, leveraging its expertise in peptide technology.

Recent filings

Filing Released Lang Actions
TR-1: Notification of major holdings
Major Shareholding Notification Classification · 1% confidence The document is explicitly titled 'TR-1: Standard form for notification of major holdings' and contains structured data fields typical of regulatory filings concerning changes in share ownership thresholds. Specifically, it details an 'acquisition or disposal of voting rights' by 'Alora Pharmaceuticals LLC' and reports the resulting percentage of voting rights (3.83%). This directly corresponds to the definition of a Major Shareholding Notification. The presence of 'RNS Number' and reference to the 'FCA' confirms it is a regulatory announcement, but the content is specifically about shareholding changes, matching the 'MRQ' code better than the general 'RNS' fallback.
2022-01-10 English
TR-1: Notification of major holdings
Major Shareholding Notification Classification · 1% confidence The document is explicitly titled 'TR-1: Standard form for notification of major holdings' and contains fields detailing changes in voting rights percentages (e.g., 7.72% resulting situation vs. 8.88% previous notification) for a specific shareholder ('Luca & Associates AG'). This structure is characteristic of regulatory filings related to significant ownership changes. The presence of 'RNS Number' and the mention of the 'FCA' (Financial Conduct Authority) confirms it is a regulatory disclosure. The category 'Major Shareholding Notification' (MRQ) perfectly matches this content, which reports when an investor crosses a major holding threshold.
2022-01-05 English
Holding(s) in Company
Major Shareholding Notification Classification · 1% confidence The document is explicitly labeled with 'RNS Number : 7556W' and contains the header 'TR-1: Standard form for notification of major holdings'. This form is used to report changes in significant share ownership, which directly corresponds to the definition of Major Shareholding Notification. Although it is distributed via RNS (London Stock Exchange news service), the core content is the notification of a change in holding percentage (from 5.71% to 12.49%) by Lanstead Capital Investors LP. Therefore, the most specific classification is Major Shareholding Notification (MRQ).
2021-12-24 English
Subscriptions and Placing to raise £3.55 million
Share Issue/Capital Change Classification · 1% confidence The document is an official announcement from Immupharma PLC, identified by the RNS Number (1210W) and the header indicating it is being distributed via a Regulatory Information Service (RNS). The content details a significant corporate action: 'Subscriptions and Placing to raise £3.55 million' and the entry into a 'Sharing Agreement'. This clearly relates to fundraising and capital structure changes. The filing type 'CAP' (Capital/Financing Update) is the most appropriate classification for an announcement detailing the raising of new capital through subscriptions and placings. Although it is distributed via RNS, the core subject matter is financing, making CAP more specific than the general 'RNS' fallback.
2021-12-20 English
Price Monitoring Extension
Share Issue/Capital Change Classification · 1% confidence The document explicitly starts with 'RNS Number : 7942V' and mentions 'RNS, the news service of the London Stock Exchange' multiple times. The content itself is a brief announcement regarding a 'Price Monitoring Extension' for a security, which is a type of market operational update. This type of short, specific regulatory announcement that doesn't fit into the major financial reporting categories (like 10-K, ER, IR) is best classified under the general regulatory announcement category, RNS, as it is distributed via the RNS system.
2021-12-15 English
Second Price Monitoring Extn
Regulatory Filings Classification · 1% confidence The document is very short (1932 characters) and contains the header 'RNS Number : 8836U' and mentions 'RNS, the news service of the London Stock Exchange'. The content describes a 'Second Price Monitoring Extension' for a security, which is a specific operational announcement related to trading halts or extensions. This type of brief, specific regulatory update that doesn't fit into the main financial reporting categories (like 10-K, ER, IR) is best classified as a general Regulatory Filing (RNS), as it is explicitly distributed via the RNS system.
2021-12-07 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.